Surgery Ev To Sales from 2010 to 2024

SGRY Stock  USD 23.84  0.43  1.84%   
Surgery Partners EV To Sales yearly trend continues to be fairly stable with very little volatility. EV To Sales is likely to outpace its year average in 2024. EV To Sales is the Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue. View All Fundamentals
 
EV To Sales  
First Reported
2010-12-31
Previous Quarter
2.50940833
Current Value
2.96
Quarterly Volatility
1.35437928
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Surgery Partners financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Surgery Partners' main balance sheet or income statement drivers, such as Depreciation And Amortization of 80.6 M, Interest Expense of 148.4 M or Selling General Administrative of 80.8 M, as well as many indicators such as Price To Sales Ratio of 1.52, Dividend Yield of 0.0014 or PTB Ratio of 2.12. Surgery financial statements analysis is a perfect complement when working with Surgery Partners Valuation or Volatility modules.
  
Check out the analysis of Surgery Partners Correlation against competitors.
For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.

Latest Surgery Partners' Ev To Sales Growth Pattern

Below is the plot of the Ev To Sales of Surgery Partners over the last few years. It is the Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue. Surgery Partners' EV To Sales historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Surgery Partners' overall financial position and show how it may be relating to other accounts over time.
Ev To Sales10 Years Trend
Slightly volatile
   Ev To Sales   
       Timeline  

Surgery Ev To Sales Regression Statistics

Arithmetic Mean3.11
Geometric Mean2.85
Coefficient Of Variation43.61
Mean Deviation1.17
Median2.51
Standard Deviation1.35
Sample Variance1.83
Range4.0313
R-Value(0.65)
Mean Square Error1.14
R-Squared0.42
Significance0.01
Slope(0.20)
Total Sum of Squares25.68

Surgery Ev To Sales History

2024 2.96
2023 2.51
2022 2.05
2021 3.04
2020 2.31
2019 1.95
2018 1.56

About Surgery Partners Financial Statements

Surgery Partners investors use historical fundamental indicators, such as Surgery Partners' Ev To Sales, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Surgery Partners. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EV To Sales 2.51  2.96 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Surgery Stock Analysis

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.